These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 17388953

  • 1. Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis.
    Rodriguez M.
    Brain Pathol; 2007 Apr; 17(2):219-29. PubMed ID: 17388953
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo models of multiple sclerosis.
    van der Star BJ, Vogel DY, Kipp M, Puentes F, Baker D, Amor S.
    CNS Neurol Disord Drug Targets; 2012 Aug; 11(5):570-88. PubMed ID: 22583443
    [Abstract] [Full Text] [Related]

  • 3. The benefits and detriments of macrophages/microglia in models of multiple sclerosis.
    Rawji KS, Yong VW.
    Clin Dev Immunol; 2013 Aug; 2013():948976. PubMed ID: 23840244
    [Abstract] [Full Text] [Related]

  • 4. Spontaneous and induced remyelination in multiple sclerosis and the Theiler's virus model of central nervous system demyelination.
    Miller DJ, Rodriguez M.
    Microsc Res Tech; 1995 Oct 15; 32(3):230-45. PubMed ID: 8527857
    [Abstract] [Full Text] [Related]

  • 5. Preclinical model of multiple sclerosis: Focal, chemical or viral demyelination.
    Tsirka SE, Nissen JC.
    Methods Cell Biol; 2022 Oct 15; 168():87-102. PubMed ID: 35366993
    [Abstract] [Full Text] [Related]

  • 6. Experimental models of demyelination and remyelination.
    Torre-Fuentes L, Moreno-Jiménez L, Pytel V, Matías-Guiu JA, Gómez-Pinedo U, Matías-Guiu J.
    Neurologia (Engl Ed); 2020 Oct 15; 35(1):32-39. PubMed ID: 28863829
    [Abstract] [Full Text] [Related]

  • 7. Coexpression of class I major histocompatibility antigen and viral RNA in central nervous system of mice infected with Theiler's virus: a model for multiple sclerosis.
    Lindsley MD, Patick AK, Prayoonwiwat N, Rodriguez M.
    Mayo Clin Proc; 1992 Sep 15; 67(9):829-38. PubMed ID: 1434926
    [Abstract] [Full Text] [Related]

  • 8. Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: implications for remyelination at lesions sites.
    Mecha M, Feliú A, Carrillo-Salinas FJ, Mestre L, Guaza C.
    Exp Neurol; 2013 Dec 15; 250():348-52. PubMed ID: 24148569
    [Abstract] [Full Text] [Related]

  • 9. Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis.
    Nastasijevic B, Wright BR, Smestad J, Warrington AE, Rodriguez M, Maher LJ.
    PLoS One; 2012 Dec 15; 7(6):e39595. PubMed ID: 22761835
    [Abstract] [Full Text] [Related]

  • 10. Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison.
    Dal Canto MC, Melvold RW, Kim BS, Miller SD.
    Microsc Res Tech; 1995 Oct 15; 32(3):215-29. PubMed ID: 8527856
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of central nervous system remyelination in immune and non-immune experimental models of demyelination.
    van Engelen BG, Pavelko KD, Rodriguez M.
    Mult Scler; 1997 Apr 15; 3(2):76-9. PubMed ID: 9291157
    [Abstract] [Full Text] [Related]

  • 12. A monoclonal natural autoantibody that promotes remyelination suppresses central nervous system inflammation and increases virus expression after Theiler's virus-induced demyelination.
    Miller DJ, Njenga MK, Murray PD, Leibowitz J, Rodriguez M.
    Int Immunol; 1996 Jan 15; 8(1):131-41. PubMed ID: 8671597
    [Abstract] [Full Text] [Related]

  • 13. Microglial MHC class II is dispensable for experimental autoimmune encephalomyelitis and cuprizone-induced demyelination.
    Wolf Y, Shemer A, Levy-Efrati L, Gross M, Kim JS, Engel A, David E, Chappell-Maor L, Grozovski J, Rotkopf R, Biton I, Eilam-Altstadter R, Jung S.
    Eur J Immunol; 2018 Aug 15; 48(8):1308-1318. PubMed ID: 29697861
    [Abstract] [Full Text] [Related]

  • 14. The Effect of Stereotactic Injections on Demyelination and Remyelination: a Study in the Cuprizone Model.
    Tejedor LS, Wostradowski T, Gingele S, Skripuletz T, Gudi V, Stangel M.
    J Mol Neurosci; 2017 Apr 15; 61(4):479-488. PubMed ID: 28124770
    [Abstract] [Full Text] [Related]

  • 15. Immune promotion of central nervous system remyelination.
    Rodriguez M, Miller DJ.
    Prog Brain Res; 1994 Apr 15; 103():343-55. PubMed ID: 7886217
    [Abstract] [Full Text] [Related]

  • 16. Tracking the evolution of CNS remyelinating lesion in mice with neutral red dye.
    Baydyuk M, Cha DS, Hu J, Yamazaki R, Miller EM, Smith VN, Kelly KA, Huang JK.
    Proc Natl Acad Sci U S A; 2019 Jul 09; 116(28):14290-14299. PubMed ID: 31235582
    [Abstract] [Full Text] [Related]

  • 17. [Pathogenesis of multiple sclerosis and other neural autoimmune diseases].
    Lassmann H.
    Verh Dtsch Ges Pathol; 1996 Jul 09; 80():109-15. PubMed ID: 9064993
    [Abstract] [Full Text] [Related]

  • 18. G-Protein-Coupled Receptor Gpr17 Expression in Two Multiple Sclerosis Remyelination Models.
    Nyamoya S, Leopold P, Becker B, Beyer C, Hustadt F, Schmitz C, Michel A, Kipp M.
    Mol Neurobiol; 2019 Feb 09; 56(2):1109-1123. PubMed ID: 29873041
    [Abstract] [Full Text] [Related]

  • 19. Immune mechanisms of Theiler's virus-induced demyelination.
    Kim BS, Palna JP.
    Exp Mol Med; 1999 Sep 30; 31(3):115-21. PubMed ID: 10551258
    [No Abstract] [Full Text] [Related]

  • 20. Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis.
    van Engelen BG, Miller DJ, Pavelko KD, Hommes OR, Rodriguez M.
    J Neurol Neurosurg Psychiatry; 1994 Nov 30; 57 Suppl(Suppl):65-8. PubMed ID: 7964859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.